Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Maintenance Treatment

NCT03926052 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yale University

Collaborators